Hian Leng Ngiam
Director/Board Member at ESSEX BIO-TECHNOLOGY LIMITED
Net worth: 612 230 $ as of 30/03/2024
Profile
Hian Leng Ngiam is currently the Executive Director at Essex Bio-Technology Ltd.
and the President & Director at Essex Bio-Investment Ltd.
He is also a Director at Antikor Biopharma Ltd., Essex Bio-Pharmacy Ltd., Essex Medipharma (Zhuhai) Co., Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd., Uno Medical Group Pvt Ltd., and Majeton Pte Ltd.
Mr. Ngiam completed his undergraduate degree at Imperial College London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
29/06/2023 | 2,039,000 ( 0.36% ) | 612 230 $ | 30/03/2024 |
Hian Leng Ngiam active positions
Companies | Position | Start |
---|---|---|
ESSEX BIO-TECHNOLOGY LIMITED | Director/Board Member | 18/09/2020 |
Essex Bio-Investment Ltd.
Essex Bio-Investment Ltd. Financial ConglomeratesFinance Part of Essex Bio-Technology Ltd., Essex Bio-Investment Ltd. is an investment holding There is no available country named vg company. The private company is based in Road Town, British Virgin Islands. | President | 31/12/2017 |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Essex Bio-Technology Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Zhuhai, China and was founded in 1999. | Director/Board Member | - |
Essex Bio-Pharmacy Ltd. | Director/Board Member | - |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | 20/01/2019 |
Majeton Pte Ltd. | Director/Board Member | - |
Uno Medical Group Pvt Ltd. | Director/Board Member | - |
Essex Medipharma (Zhuhai) Co., Ltd. | Director/Board Member | - |
Training of Hian Leng Ngiam
Imperial College London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ESSEX BIO-TECHNOLOGY LIMITED | Health Technology |
Private companies | 7 |
---|---|
Essex Bio-Investment Ltd.
Essex Bio-Investment Ltd. Financial ConglomeratesFinance Part of Essex Bio-Technology Ltd., Essex Bio-Investment Ltd. is an investment holding There is no available country named vg company. The private company is based in Road Town, British Virgin Islands. | Finance |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Essex Bio-Pharmacy Ltd. | Finance |
Essex Medipharma (Zhuhai) Co., Ltd. | |
Uno Medical Group Pvt Ltd. | |
Majeton Pte Ltd. | |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Essex Bio-Technology Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Zhuhai, China and was founded in 1999. | Health Technology |
- Stock Market
- Insiders
- Hian Leng Ngiam